MDS Pharma Services opens its first U.S. central lab
19 Oct 2006 -
MDS Pharma Services announced that it has established its first central lab in the United States. The new 15,000 square-foot facility, located in North Brunswick, New Jersey is now fully operational, expanding MDS Pharma Services capabilities in late stage pharmaceutical testing. It provides central lab support services for clinical trials. According to the company, the facility provides specialized
testing including molecular biology, molecular genetics, flow cytometry, and immunoassays in addition to standard safety testing.